Dr. Ullas Batra

Professional Journey

Achievements

• Attended Clinical observership programme in Immuno-oncology at National University of Health, Singapore in July 2016
• Attended ESMO Preceptorship programme in Thoracic Oncology at Singapore in Dec 2015
• Attended a 1-month preceptorship in Thoracic Oncology at MD Anderson Cancer Centre in Jan 2013 with DR F Fossella
• Attended a preceptorship programme at Royal Adelaide Hospital, Australia in October 2009
• Convener of the Delhi Thoracic Oncology Group
• Organizing Secretary of RGCON 2019 Organized the first ever BEST OF WCLC in India at Delhi in Dec 2016
• Organizing Secretary of RGCON 2016
• Co-Organizing secretary of RGCON 2015
• Coordinator for Thoracic Oncology at ICC, 2013
• Invited Faculty in various National and International Oncology Conference

Awards

• Awarded educational research grant for “Development of NGS based testing for detection of MET dysregulation in EGFR mutated NSCLC”: Novartis India, 2021
• Awarded International Innovation Grant 2021 by the American Society of Clinical Oncology for “Integration of Artificial Intelligence in NSCLC: Making of a symphony”
• Awarded educational research grant for “Concordance of IHC, FISH and NGS to detect ALK fusions in NSCLC”: Pfizer India, 2020
• Awarded education research grant for “Circulating tumour DNA as a predictive biomarker for tumour response and prolonged clinical benefit with Nivolumab in advanced non-small cell lung cancer: Bristol Meyer Squibb, 2019
• Awarded educational research grant for “Characterization of ALK variants in NSCLC using next generation sequencing: Pfizer India, 2018
• Awarded Research grant for Poster Discussion at ECLU Conference, Geneva, 2010
• Awarded Research grant for poster discussion at IASCLC conference 2008 held at Geneva, Switzerland
• Awarded Research grant for poster discussion at ECLU conference 2007 held at Lugano, Switzerland
• Awarded Research grant for poster discussion at St Gallens Breast conference 2007, Switzerland
• Awarded Research Grant for poster presentation at ESMO 2006 held at Istanbul, Turkey
• Awarded Best paper for paper titled” Indigenous developed EORTC QOL in Indian patients” at Indian Society of Oncology, Patna, 2006
• Awarded Dr K P Ganeshan, Dr B M Hegde Medal for the best outgoing student in M D (General Medicine) for the year 2004
• Awarded Varwady Hegde and Hirebettu Hegde Memorial Prize for standing First in Medicine- Thoracic Medicine and Cardiology in the year 2003
• Awarded Best Paper for Paper titled ״Association between CD4 count and opportunistic infection in HIV” at KAPICON, 2003
• Awarded Gold Medal in the subject of Pathology at the II MBBS examination held in the month of June 1998
• Awarded Best student in Pathology by Association of Microbiologists of India, Manipal in the year 1998
• Awarded Nantha Kumar Memorial Prize for the best student in pathology of Kasturba Medical College, Mangalore in the year 1998
• Awarded educational grant by Pfizer India for IHC vs FISH vs NGS for detection of ALK gene rearrangements in NSCLC
• Awarded educational grant by Pfizer India for Analysis of ALK variants by NGS in NSCLC
• Awarded educational grant by Novartis India for MET dysregulation in EGFR mutated NSCLC
• Awarded educational grant by Bristol Meyer Squibb for ctDNA monitoring in patients on Nivolumab in NSCLC
• Awarded ICON Molecular Oncology Grant for Dynamic EGFR monitoring in NSCLC

Publication

• Soo RA, Reungwetwattana T, Perroud HA, Batra U, Kilickap S, Tejado Gallegos LF, Donner N, Alsayed M, Huggenberger R, Van Tu D. Prevalence of EGFR Mutations in Patients With Resected Stages I to III NSCLC: Results From the EARLY-EGFR Study. J Thorac Oncol. 2024 Oct;19(10):1449-1459
• Mehta A, Diwan H, Nathany S, Batra U, Gupta M, Panigrahi MK, Kumar D, Mattoo S, Singh A. VCL::ROS1: A Novel ROS1 Oncogenic Fusion Detected on Next Generation Sequencing. Clin Pathol. 2024 Aug 12;17:2632010X241269373.
• Jha P, Joshi A, Mishra R, Biswal RP, Kulkarni PM, Limaye S, Babu G, Batra U, Malik P, Kumar R, Shah M, Menon N, Rauthan A, Kuriakose M, Ramachandran V, Noronha V, Kumar P, Prabhash K. Landscape of Clinically Relevant Genomic Alterations in the Indian Non-small Cell Lung Cancer Patients. Clin Lung Cancer. 2024 Jul 22:S1525-7304(24)00149-9.
• Noronha V, Budukh A, Chaturvedi P, Anne S, Punjabi A, Bhaskar M, Sahoo TP, Menon N, Shah M, Batra U, Nathany S, Kumar R, Shetty O, Ghodke TP, Mahajan A, Chakrabarty N, Hait S, Tripathi SC, Chougule A, Chandrani P, Tripathi VK, Jiwnani S, Tibdewal A, Maheshwari G, Kothari R, Patil VM, Bhat RS, Khanderia M, Mahajan V, Prakash R, Sharma S, Jabbar AA, Yadav BK, Uddin AFMK, Dutt A, Prabhash K. Uniqueness of lung cancer in Southeast Asia. Lancet Reg Health Southeast Asia. 2024 Jul 8;27:100430.
• Mankan AK, Shankar A, Limaye S, Ajaikumar BS, Nachane P, Singh N, Dawkhar S, Batra U, Bhosekar A, Ganguly S, Gawli P, Debnath K, Padalalu V, Reddy P, Sundaramoorthy S, Naveen KK, Bondarde S, Kumar P, Davis S, Ramkissoon SH, Chacko RT, Vidal L, Chico I, Hegedus A, Gupta S, Saini KS. Cancer Trials Ecosystem in India-Ready for Prime Time? JCO Glob Oncol. 2024 Jun;10:e2300405
• Shah E, Raman NS, Aggarwal MK, Jain A, Chokhani A, Murugan A, Goyal R, Darlong L, Batra U. Accuracy of endobronchial ultrasound (EBUS) in the staging of lung cancer – A comparison of staging EBUS with postoperative pathological nodal staging. Lung India. 2024 Mar 1;41(2):93-97
• Batra U, Nathany S, Nath SK, Jose JT, Sharma T, P P, Pasricha S, Sharma M, Arambam N, Khanna V, Bansal A, Mehta A, Rawal K. AI-based pipeline for early screening of lung cancer: integrating radiology, clinical, and genomics data. Lancet Reg Health Southeast Asia. 2024 Feb 14;24:100352
• Batra U, Prabhash K, Agarwal JP, Darlong L, Munshi A, Penumadu P, Thangakunam B, Bansal A. Clinical management of stage III non-small cell lung cancer in India: An expert consensus statement. Asia Pac J Clin Oncol. 2023 Dec;19(6):606-617
• Bansal N, Goyal P, Basu D, Batra U, Sachdeva N, Joga S, Jain A, Doval DC. Impact of improving infection control and antibiotic stewardship practices on nosocomial infections and antimicrobial resistance in an oncology centre from India. Indian J Med Microbiol. 2023 Sep-Oct;45:100383.
• Batra U, Nathany S, Sharma M, Saha S, Kumar D, Jose JT, Singh H. COVID-19 and Cancer: A Comparison of the Two Important Pandemic Waves in an Indian Cancer Patients’ Cohort. South Asian J Cancer. 2023 Aug 24;13(1):57-62.
• Batra U, Biswas B, Prabhash K, Krishna MV. Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer. BMJ Open Respir Res. 2023 Jun;10(1):e001492
• Pasricha S, Jajodia A, Sharma A, Bansal D, Batra U, Gupta G, Durga G, Kamboj M, Nathany S, Mehta A. Primary pulmonary NUT midline carcinoma: An elusive and a rare diagnostic entity. J Cancer Res Ther. 2023 Apr-Jun;19(3):816-818
• Mitsudomi T, Tan D, Yang JC, Ahn MJ, Batra U, Cho BC, Cornelio G, Lim T, Mok T, Prabhash K, Reungwetwattana T, Ren SX, Singh N, Toyooka S, Wu YL, Yang PC, Yatabe Y. Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in Asia. J Thorac Oncol. 2023 Apr;18(4):436-446.
• Vaid A, T R, Batra U, Krishna VM, Rangrajan B, Narayanan P, Vora A, Advani SH. Robust Guidelines for the Management of HR+ Her2- EBC: Crucial Value of CanAssist Breast. South Asian J Cancer. 2022 Aug 23;11(2):95-96
• Singla R, Jajodia A, Agrawal RK, Rao A, Pasricha S, Batra U. Comparison of RECIST and iRECIST criteria in patients with advanced lung cancer treated with nivolumab. J Cancer Res Ther. 2023 Jul-Sep;19(5):1212-1218.
• Chufal KS, Ahmad I, Bajpai R, Miller AA, Chowdhary RL, Makker J, Batra U, Nathany S, Sharief MI, Umesh P, Sharma M, Amrith P, Pahuja AK, Sethi J, Antony V, Gairola M. Tri-modality therapy in advanced esophageal carcinoma: long-term results and insights from a developing world, institutional cohort. Br J Radiol. 2023 Mar;96(1143):20220413.
• Cho BC, Kim DW, Batra U, Park K, Kim SW, Yang CT, Voon PJ, Sriuranpong V, Babu KG, Amin K, Wang Y, Sen P, Slimane K, Geater S. Efficacy and Safety of Ceritinib 450 mg/day with Food and 750 mg/day in Fasted State in Treatment-Naïve Patients with ALK+ Non-Small Cell Lung Cancer: Results from the ASCEND-8 Asian Subgroup Analysis. Cancer Res Treat. 2023 Jan;55(1):83-93
• Garg L, Pruthi M, Batra U, Doval DC, Pasricha S, Jaipuria J, Virk JS, Tiwari A. Analysis of Clinical Outcomes of Patients with Soft Tissue Sarcoma. Indian J Surg Oncol. 2022 Sep;13(3):518-524
• Pasricha S, Bansal D, Batra U, Jajodia A, Koyyala VPB, Mehta A. Large Symptomatic Sclerosing Pneumocytoma in a Young Male Smoker-A Rare and Deceptive Presentation. South Asian J Cancer. 2022 Aug 15;11(4):378-381
• Chiradoni Thungappa S, Maksud T, Raut N, Nagarkar R, Batra U, Kumar S, Parmar D; Study Investigator Group. Comparison of the Efficacy, Safety, Pharmacokinetic and Immunogenicity of UJVIRA (ZRC-3256, Trastuzumab Emtansine) With the Kadcyla (Trastuzumab Emtansine) in the Treatment of HER2-Positive Metastatic Breast Cancer: A Randomized, Open-Label, Multicenter Study in India. Clin Breast Cancer. 2022 Jun;22(4):300-307
• Batra U, Chufal KS, Nathany S, Ahmad I, Chowdhary RL, Sharma M, Jain P, Gairola M. Immunotherapy in advanced non-small-cell lung cancer (NSCLC) after progression on chemotherapy: real-world results from a prospective institutional cohort. Immunotherapy. 2022 Aug;14(11):851-858
• Jajodia A, Goel V, Patnaik N, Pasricha S, Gupta G, Batra U, Talwar V. Analysis of Spatial Heterogeneity of Responses in Metastatic Sites in Renal Cell Carcinoma Patients Treated with Nivolumab. Tomography. 2022 May 20;8(3):1363-1373
• Whisenant JG, Baena J, Cortellini A, Huang LC, Lo Russo G, Porcu L, Wong SK, Bestvina CM, Hellmann MD, Roca E, Rizvi H, Monnet I, Boudjemaa A, Rogado J, Pasello G, Leighl NB, Arrieta O, Aujayeb A, Batra U, Azzam AY, Unk M, Azab MA, Zhumagaliyeva AN, Gomez-Martin C, Blaquier JB, Geraedts E, Mountzios G, Serrano-Montero G, Reinmuth N, Coate L, Marmarelis M, Presley CJ, Hirsch FR, Garrido P, Khan H, Baggi A, Mascaux C, Halmos B, Ceresoli GL, Fidler MJ, Scotti V, Métivier AC, Falchero L, Felip E, Genova C, Mazieres J, Tapan U, Brahmer J, Bria E, Puri S, Popat S, Reckamp KL, Morgillo F, Nadal E, Mazzoni F, Agustoni F, Bar J, Grosso F, Avrillon V, Patel JD, Gomes F, Ibrahim E, Trama A, Bettini AC, Barlesi F, Dingemans AM, Wakelee H, Peters S, Horn L, Garassino MC, Torri V; TERAVOLT study group. A Definitive Prognostication System for Patients With Thoracic Malignancies Diagnosed With Coronavirus Disease 2019: An Update From the TERAVOLT Registry. J Thorac Oncol. 2022 May;17(5):661-674.
• Abraham G, Noronha V, Rajappa S, Agarwal A, Batra U, Somani N, Raja T, Patil S, Kaushal AM, Joshi A, Radhakrishnan V, Singh N, Babu G, Tewani R, Baghmar S, Dodagoudar C, Ananthakrishnan R, Haragadde Poppareddy S, Sharma V, Menon N, M Patil V, Joshi A, Gupta S, Prabhash K, Bajpai J. The clinical utility and safety of short-course immune checkpoint inhibitors in multiple tumours-A real-world multicentric study from India. Int J Cancer. 2022 Mar 15;150(6):1045-1052
• Batra U, Nathany S, Sharma M, Jain P, Mehta A. Next generation sequencing for detection of EGFR alterations in NSCLC: is more better? J Clin Pathol. 2022 Mar;75(3):164-167.
• Batra U, Munshi A, Kabra V, Momi G. Relevance of multi-disciplinary team approach in diagnosis and management of Stage III NSCLC. Indian J Cancer. 2022 Mar;59(Supplement):S46-S55. doi: 10.4103/ijc.IJC_51_21.
• Batra U, Nathany S, Sharma M, Mattoo S, Jose JT, Mehta A. Unusual Resistance Mechanisms in a Case of ROS1-Rearranged NSCLC: A Case Report. JTO Clin Res Rep. 2022 Feb 4;3(3):100286.
• Batra U, Nathany S, Sharma M, Jain P, Dhanda S, Singh H, Jain A, Mehta A. EGFR detection by liquid biopsy: ripe for clinical usage. Future Oncol. 2022 Jan;18(1):85-92
• Lee J, Tan AC, Zhou S, Yoon S, Liu S, Masuda K, Hayashi H, Batra U, Kim DW, Goto Y, Tan SH, Wu YL, Lee DH, Tan DSW, Ahn MJ. Clinical Characteristics and Outcomes in Advanced KRAS-Mutated NSCLC: A Multicenter Collaboration in Asia (ATORG-005). JTO Clin Res Rep. 2021 Dec 4;3(1):100261
• Ramaswamy A, Bajaj K, Talwar V, Prabhash K, Batra U, Dhabhar B, Sharma M, Ghadyalpatil N, Ct S, Goyal G, Muzamil J, Bhatt A, Jain P, Ranade A, Kamath M, Gawande JP, Thippeswamy R, Mirani J, Reddy N, Ganguly S, Mishra SK, Madabhavi I, Hp S, Panda SS, Patil S, Bhargava P, Ostwal V. Ramucirumab in Indian Patients with Advanced Gastric Cancer-Does Borderline Performance Status and Heavy Burden of Disease in Real World Practice Impact Clinical Benefit? South Asian J Cancer. 2021 Sep 4;11(1):24-30
• Batra U, Nathany S. Biomarker series: KRAS-A narrative review. Cancer Research, Statistics, and Treatment. 2021 Jul 1;4(3):516.
• Sharma M, Nathany S, Batra U. BRAF in lung cancer: A narrative review. Cancer Research, Statistics, and Treatment. 2021 Apr 1;4(2):328.
• Batra U, Nathany S, Bansal N, Sharma M. COVID-19 vaccination status in Indian patients with cancer: An observational study. Cancer Research, Statistics, and Treatment. 2021 Apr 1;4(2):219.
• Batra U, Sharma M, Nathany S, Jain P, Soni S, Mehta A. Are all ALK variants created equal? Clinicopathologic features and outcomes: a propensity-matched study. International Journal of Clinical Oncology. 2021 Apr 12:1-8.
• Batra U, Nathany S, Sharma M, Pasricha S, Bansal A, Jain P, Mehta A. IHC versus FISH versus NGS to detect ALK gene rearrangement in NSCLC: all questions answered? J Clin Pathol. 2022 Jun;75(6):405-409. doi: 10.1136/jclinpath-2021-207408. Epub 2021 Mar 22.
• Tripathi R, Nathany S, Mehta A, Batra U, Mattoo S, Sharma M. Malfeasance of KRAS mutations in carcinogenesis. Clinical and experimental medicine. 2021 Mar 12:1-7.
• Batra U, Nathany S. Path beyond tyrosine kinase inhibitors: Full of riddles and puzzles. Cancer Research, Statistics, and Treatment. 2021 Jan 1;4(1):182.
• Ramaswamy A, Bajaj K, Talwar V, Prabhash K, Batra U, Dhabhar B, Sharma M, Ghadyalpatil N, Satish CT, Goyal G, Muzamil J. Ramucirumab in Indian Patients with Advanced Gastric Cancer—Does Borderline Performance Status and Heavy Burden of Disease in Real World Practice Impact Clinical Benefit?. South Asian Journal of Cancer. 2021 Sep 4.
• Batra U, Nathany S, Sharma M, Bansal N. Authors’ reply to Pimple et al., Ghafur, and Potter. Cancer Research, Statistics, and Treatment. 2021 Jul 1;4(3):571.
• Batra U, Nathany S, Sharma M, Pasricha S, Bansal A, Jain P, Mehta A. IHC versus FISH versus NGS to detect ALK gene rearrangement in NSCLC: all questions answered?. Journal of Clinical Pathology. 2021 Mar 22.
• Batra U, Sharma M, Nathany S, Bansal A, Pasricha S, Jain P, Mehta A, Singh H. EGFR and PDL1: A Match (Not) Made in Heaven—A Real-World Retrospective Analysis of PDL1 Expression in EGFR- Mutated NSCLC. Advances in Therapy. 2021 Apr;38(4):1791-800.
• Batra U, Nathany S, Sharma M. NTRK-A narrative review. Cancer Research, Statistics, and Treatment. 2021 Jan 1;4(1):110.
• Batra U, Nathany S, Sharma M, Jain P, Bansal A. KRAS mutation as a mechanism of resistance to Alectinib in ALK rearranged NSCLC. Current Problems in Cancer: Case Reports. 2021 Mar 1;3:100055.
• Batra U, Nathany S, Sharma M. Authors’ reply to Rasalkar et al. Cancer Research, Statistics, and Treatment. 2021 Jan 1;4(1):179.
• Batra U, Nathany S. Path beyond tyrosine kinase inhibitors: Full of riddles and puzzles. Cancer Research, Statistics, and Treatment. 2021 Jan 1;4(1):182.
• Batra U, Nathany S, Sharma M, Soni S, Jain P, Pasricha S, Bansal A, Mehta A. Identification of a novel ALK variant intrinsically resistant to crizotinib. Current Problems in Cancer: Case Reports. 2020 Dec 15;2:100040.
• Batra U, Sharma M, Nathany S, Soni S, Bansal A, Jain P, Mehta A. Biomarker testing in non-small cell lung carcinoma–More is better: A case series. Cancer Research, Statistics, and Treatment. 2020 Oct 1;3(4):742.
• Batra U, Nathany S, Sharma M, Jain P, Mehta A. Next generation sequencing for detection of EGFR alterations in NSCLC: is more better?. Journal of clinical pathology. 2020 Dec 28.
• Batra U, Bapsy P, Dadhich H, Saini K, Atili V, Babu K. An unusual case of gastric cancer presenting as bone and marrow metastases. Aust-Asian J Cancer. 2007;6(3):151-3.
• Batra U, Sharma M, Redhu P. Chloroquine and hydroxychloroquine: Clutching at straws in the time of COVID-19?. Cancer Res Stat Treat 2020;3, Suppl S1:3-6
• Batra U, Sharma M, Amrith BP, Mehta A, Jain P. EML4-ALK Fusion as a Resistance Mechanism to
• Osimertinib and Its Successful Management With Osimertinib and Alectinib: Case Report and Review of the Literature. Clin Lung Cancer. 2020 May 23:S1525-7304(20)30156-X. doi: 10.1016/j.cllc.2020.05.016. Epub ahead of print. PMID: 32620470
• Ullas Batra, Shrinidhi Nathany, Anurag Mehta, Dinesh Bhurani, Mansi Sharma, Parveen Jain, Narender Tejwani, Successful treatment of de novo multiple primary malignancy with long term favorable outcome,Current Problems in Cancer: Case Reports,Volume 2,2020, ,ISSN 2666- 6219,https://doi.org/10.1016/j.cpccr.2020.100030.
• Ullas Batra, Shrinidhi Nathany, Mansi Sharma et al., Successful treatment of EGFR mutant Synchronous Small cell carcinoma and Adenocarcinoma Lung with osimertinib, September 12, 2020, JTOCRR, doi: https://doi.org/10.1016/j.jtocrr.2020.100098
• Batra, U., Mahawar, V., Jajodia, A., Razdan, A., Mahanthi, H., & Koyyala, V. P. B. (2019). Patterns of brain metastasis in anaplastic lymphoma kinase-rearranged and epidermal growth factor receptor- mutated lung cancer patients in magnetic resonance imaging. South Asian journal of cancer, 8(3), 189
• Batra, U., Sharma, M., Joga, S., & Jain, P. (2019). First-line treatment of EGFR-mutant NSCLC: Spoiled for choice? Cancer Research, Statistics, and Treatment, 2(2), 251
• Batra, U., Koyyala, V. P. B., Jain, A., Agrawal, C., & Maheswari, U. (2017). care. Gradually, her kidney function tests normalized, and her sensorium normalized within 72 hours. South Asian Journal of Cancer, 6(2), 87
• Batra U, S., Doval, D. C., Batra, U., Suresh, P., Dhiman, A. and Talwar, V. Gallbladder cancer with tumor thrombus in the superior vena cava. Hepatobiliary& Pancreatic Diseases International : HBPD INT. 2010. 9, 325-328
• Batra, U., Mahawar, V., Jajodia, A., Razdan, A., Mahanthi, H., &BabuKoyyala, V. P. (2019). Patterns of brain metastasis in anaplastic lymphoma kinase – rearranged and epidermal growth factor receptor- mutated lung cancer patients in magnetic resonance imaging. South Asian journal of cancer, 8(3), 189–190
• Batra U, Aggarwal M, Jain P, Goyal P, Yadav A, Maheshwari U, Mehta A. Clinical outcome study of crizotinib in immunohistochemistry-proven echinoderm microtubule-associated protein-like 4- anaplastic lymphoma kinase fusion gene among Indian patients with adenocarcinoma lung. South Asian J Cancer. 2018 Jan-Mar;7(1):61-64
• Batra U, Koyyala VPB, Jain A, Agrawal C, Maheswari U. Folfox encephalopathy: A rare case series. South Asian J Cancer. 2017 Apr-Jun;6(2):86-87
• Batra U, Sharma M, Amrith BP. Molecular tumor boards: Demystifying complex algorithms in non- small cell lung cancer. Cancer Research, Statistics, and Treatment. 2020 Jan 1;3(1):153
• Batra U, Lokeshwar N, Gupta S, Shirsath P. Role of epidermal growth factor receptor-tyrosine kinase inhibitors in the management of central nervous system metastases in epidermal growth factor receptor mutation-positive nonsmall cell lung cancer patients.Indian J Cancer. 2017 Dec;54(Supplement):S37-S44
• Batra U, Sharma M. Association of Vitamin D with cancer–Catch me if you can!. Cancer Research, Statistics, and Treatment. 2020 Jan 1;3(1):78.
• Batra U, Jain A, Sharma M, Bajaj R, Suryavanshis M. Role of crizotinib in c-mesenchymal-epidermal transition-positive nonsmall cell lung cancer patients.Indian J Cancer. 2017 Jan-Mar;54(1):178-181
• Batra U, Babu P, Agarwal C, et al. FOLFOX encepaholapthy: A Rare case series. South Asian J Cancer Nov, 2017
• Batra U, Goyal P, Jain P, et al. Epidemiology and resistance patterns of bacterial isolates among cancer patients in a tertiary cancer Oncology Centre in North India. Indian J Cancer
• Batra U, Parikh PM, Prabhash K, etal.Practical consensus recommendation 2016 for advanced clear cell RCC. South asian J Cancer. Oct-Dec 2016: ; 5(4): 196-204
• Batra U, Bapsy PP, DadhichHK,et al. An unusual case of stomach carcinoma presenting with only bone and bone marrow metastases. AJC, Jan 2011
• Batra U, Parikh PM, Prabhash K, Tongaonkar HB, Members EG, Chibber P, Dabkara D, Deshmukh C, Ghadyalpatil N, Hingmire S, Joshi A. Oncology Gold Standard™ practical consensus recommendations 2016 for treatment of advanced clear cell renal cell carcinoma. South Asian journal of cancer. 2016 Oct;5(4):167.
• Agrawal C, Goyal P, Agarwal A, Tripathi R, Dodagoudar C, Baghmar S, Sharma A, Batra U, Talwar V, Goyal S, Kumar R. Multicentric real world evidence with palbociclib in hormone positive HER2 negative metastatic breast cancer in Indian population. Scientific Reports. 2021 Aug 10;11(1):1-6.
• Kumar S, Joga S, Biswas B, Dabkara D, Prasad KT, Singh N, Malik PS, Khurana S, Ganguly S, Muthu V, Batra U. Immune checkpoint inhibitors in advanced non–small cell lung cancer: A metacentric experience from India. Current Problems in Cancer. 2020 Jan 23:100549.
• Jain A, Suryavanshi M, Batra U, Goyal P, Doval D. Circulating tumor cells in breast cancer. International Journal. 2017 Jan;2(1):5.
• Moushumi Suryavanshi, Jiten Jaipuria, Manoj Kumar Panigrahi, Neha Goyal,Rishu Singal, Anurag Mehta, Ullas Batra, D.C. Doval, Vineet Talwar. CSF cell-free DNA EGFR testing using DdPCR holds promise over conventional modalities for diagnosing leptomeningeal involvement in patients with non-small cell lung cancer.Lung Cancer. 2020 Oct 5;148:33-39. Epub 2020 Aug 5
• Bothra, S.J., Sharma, M., Jain, P., Bansal, D. and Batra, U., Epithelioid rhabdomyosarcoma: A rare case report mimicking carcinoma breast. Indian Journal of Medical Sciences, pp.1-3.m
• Mehta A, Batra U, Sharma M, Sharma S,Nathany S.Detection of rare targetable EGFR variant in Metastatic Non-small Cell Lung Carcinoma by next Generation Sequencing: A Case Report
• [Internet].2020 June [Cited September21, 2020];14(6):GD01-GD03
• Basnet, B., Goyal, P., Mahawar, V., Bothra, S. J., Agrawal, C., Thapa, B. B., Talwar, V., Jain, P., BabuKoyyala, V. P., Goel, V., Batra, U., &Doval, D. C. (2020). Role of 18F-Flurodeoxyglucose Positron- Emission Tomography/Computed Tomography in the Evaluation of Early Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Triple-Negative Breast Cancer. Indian journal of nuclear medicine: IJNM: the official journal of the Society of Nuclear Medicine, India, 35(2), 105–109
• Goel A, Shah SH, Selvakumar VP, Kahkasha S, Garg S, Pahuja AK, Dutta K, Batra U, Sharma SK, Doval DC, Kumar K. Radical esophagectomy after neoadjuvant chemoradiation: single institutional experience from Tertiary Cancer Centre in India. Indian journal of surgical oncology. 2015 Sep 1;6(3):207-12.
• Gupta M, Choudhury PS, Rao SA, Jain P, Sharma M, Babu VP, Goyal S, Pasricha S, Batra U. A comparative study of immune RECIST and immune adaptive PERCIST in non small cell lung cancer patients treated with nivolumab. Journal of Nuclear Medicine. 2020 May 1;61(supplement 1):242- 242.
• Prabhash, Kumar, Bivas Biswas, Sachin Khurana, Ullas Batra, Ghanashyam Biswas, Suresh Hariram Advani, P. Mohapatra et al. “CONCORDANCE study: An observational, multicenter, prospective study to evaluate concordance of detecting EGFR mutations by circulating tumor-free DNA versus tissues biopsy in NSCLC.” (2020): e21615-e21615.
• Garg, A., Batra, U., Choudhary, P., Jain, D., Khurana, S., Malik, P. S., & Mohan, A. (2020). Clinical predictors of response to EGFR-tyrosine kinase inhibitors in EGFR-mutated non-small cell lung cancer: A real-world multicentric cohort analysis from India. Current Problems in Cancer, 100570
• Patel, A., Batra, U., Prasad, K. T., Dabkara, D., Ghosh, J., Sharma, M., & Choudhary, P. (2020). Real world experience of treatment and outcome in ALK-rearranged metastatic non small cell lung cancer: A multicenter study from India. Current Problems in Cancer, 100571
• Mehta, A., Nathany, S., Tripathi, R., Sharma, S. K., Saifi, M., & Batra, U. (2020). Non-amplification genetic alterations of HER2 gene in non-small cell lung carcinoma. Journal of Clinical Pathology
• Pasricha, S., Menon, V., Gupta, G., Kamboj, M., Sharma, A., Durga, G., Batra U & Agrawal, C. Impact of 2018 ASCO/CAP guidelines on HER‐2 reporting categories of IHC and reflex FISH in breast cancer. The Breast Journal
• Mehta, A., Saifi, M., Batra, U., Suryavanshi, M., & Gupta, K. (2020). Incidence of ROS1-Rearranged Non-Small-Cell Lung Carcinoma in India and Efficacy of Crizotinib in Lung Adenocarcinoma Patients. Lung Cancer: Targets and Therapy, 11, 19
• Doval, D. C., Radhakrishna, S., Tripathi, R., Kashinath, R. I., Talwar, V., Batra, U., & Tayal, J. (2020). A multi-institutional real world data study from India of 3453 non-metastatic breast cancer patients undergoing upfront surgery. Scientific Reports, 10(1), 1-10
• Basnet, B., Goyal, P., Mahawar, V., Bothra, S. J., Agrawal, C., Thapa, B. & Batra, U. (2020). Role of 18F-Flurodeoxyglucose Positron-Emission Tomography/Computed Tomography in the Evaluation of Early Response to Neoadjuvant Chemotherapy in Patients with Locally Advanced Triple-Negative Breast Cancer. Indian Journal of Nuclear Medicine: IJNM: The Official Journal of the Society of Nuclear Medicine, India, 35(2), 105
• Chandra D, Chandra Doval D, Suresh P, Sinha R, Azam S, Batra U, Talwar V, Kumar K, Mehta A. Eight year survival analysis of patients with triple negative breast cancer in India. Asian Pacific Journal of Cancer Prevention. 2016 Jul 1;17(6):2995-9.
• Suryavanshi, M., Jaipuria, J., Panigrahi, M. K., Goyal, N., Singal, R.,Batra U, Mehta, A., & Talwar, V. (2020). CSF cell-free DNA EGFR testing using DdPCR holds promise over conventional modalities for diagnosing leptomeningeal involvement in patients with non-small cell lung cancer. Lung Cancer
• Gooptu M, Doval D, Kumar K, Dewan A, Mehta A, Batra U, Dutta K, Avery TP, Jaslow RJ, Mitchell EP, Naiyer A. Breast cancer in low-income countries: India as a model.
• Mehta, A., Saifi, M., Batra, U., Suryavanshi, M., & Gupta, K. (2020). Incidence of ROS1-Rearranged Non-Small-Cell Lung Carcinoma in India and Efficacy of Crizotinib in Lung Adenocarcinoma Patients. Lung Cancer (Auckland, N.Z.), 11, 19–25
• Doval, D. C., Tripathi, R., Choudhury, K. D., Sharma, A., Batra, U., Mehta, A., & Choudhury, P. S. (2019). Case Report of Non-small Cell Lung Cancer Patient with EGFR T790M Mutation Treated with Third Generation Inhibitor. Indian Journal of Medical Sciences, 71(1), 49-51
• Doval DC, Tripathi R, Choudhury KD, Sharma A, Batra U, Mehta A, Choudhury PS. Synergistic Occurrence of EGFR, ALK, and KRAS Gene Mutations in a Patient with Non-small Cell Lung Cancer (Adenocarcinoma). Indian Journal of Medical Sciences. 2019 Oct 19;71(1):45-8.
• Goyal P, Chaudhari KA, Batra U, Jain P, Agrawal C, Talwar V, Goyal S, Bothra S, Domadia K, Babu VP, Doval DC. Study of efficacy and tolerability of paclitaxel and carboplatin as a concurrent chemotherapeutic radiation sensitizer regimen in patients of esophageal cancer: Prospective observational study from tertiary center in northern India.
• Sharma, M., Goyal, S., Gupta, M., Batra, U., Jajodia, A., & Babu, V. P. (2019). A rare case of cardiac metastasis from non-small cell lung cancer. Journal of Indian College of Cardiology, 9(1), 50
• Jain, P., Doval, D. C., Batra, U., Goyal, P., Bothra, S. J., Agarwal, C., & Dash, P. (2019). Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancer. Japanese journal of clinical oncology, 49(4), 329-338
• Mehta A, Vasudevan S, Sharma SK, Panigrahi M, Suryavanshi M, Saifi M, Batra U. Biomarker testing for advanced lung cancer by next-generation sequencing; a valid method to achieve a comprehensive glimpse at mutational landscape. Applied Cancer Research. 2020 Dec;40:1-2.
• Prabhash, K., Advani, S. H., Batra, U., Biswas, B., Chougule, A., Ghosh, M., & Vaid, A. K. (2019). Biomarkers in non-small cell lung cancers: Indian consensus guidelines for molecular testing. Advances in therapy, 36(4), 766-785
• Rajappa, S. K., Maheshwari, U., Jaipuria, J., Singh, A. K., Goyal, S., Batra, U., & Dewan, A. K. (2019). Number of positive nodes–Current relevance in determining prognosis of oral cavity cancer after the recent AJCC staging update. Oral oncology, 90, 1-5
• Lau, S. C., Batra, U., Mok, T. S., & Loong, H. H. (2019). Dacomitinib in the Management of Advanced Non-Small-Cell Lung Cancer. Drugs, 1-9
• Goyal, Pankaj, Udip Maheshwari, Parveen Jain, Chaturbhuj Agrawal, Krushna A. Chaudhari, Sumit Goyal, Ullas Batra et al. “Rectal cancer in young patients: Clinicoepidemiologic profile and treatment outcomes.” (2020): 4042-4042.
• Doval, D. C., Azam, S., Sinha, R., Batra, U., Mehta, A., & Rao, A. (2015). A report of two cases of leptomeningeal carcinomatosis arising from gallbladder carcinoma. Journal of gastrointestinal cancer, 46(4), 417-420
• Hibare, K. R., Goyal, R., Nemani, C., Avinash, R., Ram, B., & Ullas, B. (2017). Radial endobronchial ultrasound for the diagnosis of bronchoscopically invisible lesions: First case series from India. Lung India: Official Organ of Indian Chest Society, 34(1), 43
• Amrith, B. P., Jain, P., Chaudhari, K. A., Sharma, M., &Batra, U. (2019). Severe hypoglycemia with trastuzumab: An unseen adverse event. South Asian journal of cancer, 8(3), 149
• Cho BC, Obermannova R, Bearz A, McKeage M, Kim DW, Batra U, et al. Efficacy and Safety of Ceritinib (450 mg/day or 600 mg/day) With Food vs. 750 mg/day Fasted in Patients With ALK- Positive NSCLC: Primary Efficacy Results From ASCEND-8 Study. J ThoracOncol. 2019 Mar 6.pii: S1556-0864(19)30195-9
• Rajappa, S. K., Maheshwari, U., Jaipuria, J., Singh, A. K., Goyal, S., Batra, U., & Dewan, A. K. (2019). Number of positive nodes–Current relevance in determining prognosis of oral cavity cancer after the recent AJCC staging update. Oral oncology, 90, 1-5
• Jain P, Doval DC, Batra U, Goyal P, Bothra SJ, Agarwal C,et al. Ki-67 labeling index as a predictor of response to neoadjuvant chemotherapy in breast cancer.Jpn J ClinOncol. 2019 Feb 12
• BabuKoyyala VP, Batra U, Jain P, Sharma M, Goyal P, MedisettyP, et al. Frequency of T790M mutations after progression on epidermal growth factor receptor tyrosine kinase inhibitor in metastatic non-small cell lung cancer in Indian patients: real-time data from tertiary cancer hospital. Lung India. 2018 Sep-Oct;35(5):390-394
• Suryavanshi M, Mehta A, Panigrahi MK, Jaipuria J, Saifi M, Jain K, Kumar D, Verma H, Sharma SK,Batra U, Dutta K, Talwar V, Doval DC. The detection of primary and secondary EGFR mutations using droplet digital PCR in patients with non-small cell lung cancer. Lung India. 2018 Sep-Oct;35(5):384- 389
• Rajappa S, Joshi A, Doval DC, Batra U, Rajendranath R, Deo A, et al. Novel formulations of docetaxel, paclitaxel and doxorubicin in the management of metastatic breast cancer. Oncol Lett. 2018 Sep;16(3):3757-3769
• Babu Koyyala VP, Batra U, Jain P, Sharma M, Goyal P, Domadia K, Botra S. Good response to erlotinib in a patient after progression on osimertinib: A rare case of spatiotemporal T790M heterogeneity in a patient with epidermal growth factor receptor-mutant non small cell lung cancer. South Asian J Cancer. 2017 Oct-Dec;6(4):179
• Mehta A, Batra U. Molecular epidemiological study of microtubule-associated protein-like 4- anaplastic lymphoma kinase fusion gene using immunohistochemistry as a cost effective alternative to fluorescence in situ hybridization for Indian patients with adenocarcinoma lung. Asian Journal of Oncology. 2017;3(1).
• Tandon S, Gairola M, Pal M, Aggarwal A, Sharma K, Karimi AM, Mandal A, Goyal R, Batra U, Kaur I. The use of adaptive intensity-modulated radiotherapy in the treatment of small-cell carcinoma lung refractory to chemotherapy in a patient with preexisting interstitial lung disease. Lung India. 2018 Jan-Feb;35(1):54-57
• Suryavanshi M, Panigrahi MK, Kumar D, Verma H, Saifi M, Dabas B, Batra U, Doval D, Mehta A. ROS1 rearrangement and response to crizotinib in Stage IV non-small cell lung cancer. Lung India. 2017 Sep-Oct;34(5):411-414
• Gupta M, Datta A, Choudhury PS, Dsouza M, Batra U, Mishra A. Can 18F-Fluoroestradiol Positron Emission Tomography Become a New Imaging Standard in the Estrogen Receptor-positive Breast Cancer Patient: A Prospective Comparative Study with 18F-Fluorodeoxyglucose Positron Emission Tomography? World J Nucl Med. 2017 Apr-Jun;16(2):133-139
• Tiwari A, Shah S, Sharma AK, Mehta S, Batra U, Sharma SK, Dewan AK. Prognostic Factors in Indian Patients Operated for Soft Tissue Sarcomas-a Retrospective Cross-sectional Analysis. Indian J SurgOncol. 2017 Jun;8(2):128-135
• Suryavanshi M, Shah A, Kumar D, Panigrahi MK, Metha A, Batra U. MET Amplification and Response to MET Inhibitors in Stage IV Lung Adenocarcinoma.Oncol Res Treat. 2017;40(4):198-202.
• Doval DC, Sinha R, Batra U, Choudhury KD, Azam S, Mehta A. Clinical profile of nonsmall cell lung carcinoma patients treated in a single unit at a tertiary cancer care center.Indian J Cancer. 2017 Jan- Mar;54(1):193-196
• Babu KV, Aggarwal C, Batra U, et al. Rapidly Progressive Skin Metastasis in EGFR Wild and ALK Fusion Negative Adenocarcinoma Lung: An Unusual Presentation. Lung Cancer May 2017
• Sharma M, Joga S, Batra U. Liquid biopsy in non-small-cell lung cancer: Ready for prime time?. Cancer Research, Statistics, and Treatment. 2020 Jan 1;3(1):142.
• Goyal P, Batra U, agarwal C, et al. Efficacy and toxicity profile of maintenance pemetrexed in patients with stage IV adenocarcinoma lung in Indian population. South Asian J Cancer 2016 Oct – Dec ; 5(4): 196-204
• Tiwari A, Shah S, Sharma AS, Batra U, et al. Prognostic factors in Indian patients operated for soft tissue sarcoma – a retrospective cross sectional analysis. Indian J Surg Oncology
• Saini R, Batra U, et al. EGFR mutation – a commonly neglected mutation in squamous cell lung cancer. Journal of Cancer treatment and metastasis 2016:20(2);253-4
• Vaid A, Prabhash K, Batra U. Concordance Of Detecting Egfr Mutation By Circulating Tumour Free Dna Versus Tissues Biopsy In Nsclc: Study Design. Journal of Cancer Research & Therapeutics. 2017 Dec 2;13.
• Jajodia A, Sindhwani G, Pasricha S, Prosch H, Puri S, Dewan A, Batra U, Doval DC, Mehta A, Chaturvedi AK. Application of the Kaiser score to increase diagnostic accuracy in equivocal lesions on diagnostic mammograms referred for MR mammography. European Journal of Radiology. 2020 Nov 30;134:109413.
• Doval DC, Sharma S, Sinha R, Batra U et al. Profile of Breast Cancer Patients at a Tertiary Care Hospital in New Delhi, India.Asian Pac J Cancer Prev 2015 ;16(12):4959-64
• Doval DC, Sinha R, Batra U, et al. A Report of Two Cases of LeptomeningealCarcinomatosis Arising from Gallbladder Carcinoma.JGastrointest Cancer 2015 Apr 12. Epub 2015 Apr 12
• Doval DC, Azam S, Sinha R, Batra U, et al.Expression of epidermal growth factor receptor, p53, Bcl2, vascular endothelial growth factor, cyclooxygenase-2, cyclin D1, human epidermal receptor-2 and Ki-67: Association with clinicopathological profiles and outcomes in gallbladder carcinoma.JCarcinog 2014 25;13:10
• Doval DC, Azam S, Mehta A, Batra U et al.A report of sarcomatoid carcinoma of the gallbladder treated with palliative deocetaxel and gemcitabinechemotherapy.JGastrointest Cancer 2014 Dec;45 Suppl 1:270- 4
• Doval DC, Batra U, GoyalS , et al Chronic myeloid leukemia treatment with Imatinib: An experience from a private tertiary care hospital.Indian J Med PaediatrOncol 2013 Jul;34(3):182-5
• Suresh P, Batra U, Doval DC, et al.Epidemiological and clinical profile of triple negative breast cancer at a cancer hospital in North India.Indian J Med PaediatrOncol 2013 Apr;34(2):89-95
• Doval DC, Azam S, Batra U, et al. Epidermal growth factor mutation in NSCLC: A single centre Experience. Carcinog 2013:12;12
• Doval DC, Dutta K, Batra U, etal.Neoadjuvant chemotherapy in breast cancer. A review of literature.Indian Med Assoc 2013;111(9): 629-31
• Singh T, Premlata S, Sajeevan K, Batra U et al.IgA plasma cell leukemia.J Lab Physicians 2009 Jan;1(1):19-21
• Singh T, Sajeevan K, Jain A, Batra U, et al.Blindness as an initial presentation of rectal cancer with brain metastases. Saudi J Gastroenterol 2009 Jan;15(1):63-4
• Suresh AVS, Batra U, Bapsy PP, et al.Skin nodules as a presenting feature of diffuse large B-cell gastric lymphoma. Indian J Dermatol 2008 Jan;53(1):39-40
• Pasricha S, Bansal D, Batra U, Durga G, Kamboj M, Gupta G, Sharma A, Pahuja A, Jajodia A, Jain V, Gupta M. Metastatic low-grade myoepithelial carcinoma of lung managed with low-dose external beam radiotherapy. Indian Journal of Pathology and Microbiology.;64(1):155.
• Pasricha S, Grover S, Kamboj M, Bansal D, Batra U, Gupta G, Sharma A, Durga G, Jajodia A, Koyyala VP, Mehta A. Hepatoid adenocarcinoma of lung: A diagnostic challenge-Series of six cases with histopathological, predictive molecular and PD. L1 assessment. Indian Journal of Pathology and Microbiology.;64(1):128.
• Atilli AVS, Jain A, saini KVS, Batra U. Orbital Metastases: A rare presentation of osteosarcoma. International Ophthalmology 2008; 28: 433-6
• Suresh Attili VS, Kamal S, Lakshmaiah KC, Ullas B, Malathi M, Ramachandra C. Case Report- Malignant adenomyoepithelioma of the breast. Indian Journal of Surgery. 2007;69(1):14-6.
• Attili V, Bapsy PP, Dadhich HK, Batra U, Lokanatha D, Babu KG. Impact of diabetes on cancer chemotherapy outcome: A retrospective analysis. International Journal of Diabetes in Developing Countries. 2007 Dec 1;27(4).
• Ankit J, Premalata CS, Saini KV, Bapsy PP, Sajeevan KV, Singh T, Batra U, Govind B, Dasappa L, Atilli S. Acute myeloid leukemia following radioactive iodine therapy for papillary carcinoma of the thyroid. Turkish Journal of Hematology. 2009 Jun 1;26(2).
• Attili S, Ullas B, Lakshm D, Bapsy PP, Lakshm KC, Govind K, Lokana D, Kamal S, Anupam G. Malignant myelomatous pleural effusion-Is onset of effusion a new prognostic factor? Turk J Hematol. 2007; 24:180-4.
• Kamal S Saini, Suresh V Attili, Monika LambaSaini, Ullas Batra.Capecitabine-induced Hand-foot Syndrome. JIACM 2007;8(2): 144-5
• Suresh AVS, Batra Ullas, Dadhich H, et al. A case of carcinoma lung presenting as pancytopenia. AAJC 2006:5(3);131-2
• Suresh AS, Loknath PP, Bapsy PP, Anupama G, Dadhich HK, Ravikiran B, Batra U. Acute myeloid leukemia with isolated CNS relapse. Indian Journal of Medical and Paediatric Oncology. 2006 Apr 1;27(2):42.
• Maalathi Prabhu, Naidu S, Batra Ullas. Familial presentation of SLE. JIACM 2003;4(3): 247-8
• Upadhyay A, Goel V, Batra U, Goyal P, Dutta K, Aggarwal M, Doval DC. Two cases of ovarian carcinoma with endobronchial metastases: Rare presentation. South Asian journal of cancer. 2015 Jul;4(3):149.
• Lamba M, Mukherjee G, Saini K, Ramachandra C, Rao C, Kumar R, Bapsy P, Babu K, Attili S, Batra U. Clinico-pathologic pattern of gastrointestinal stromal tumors (GIST) in southern India: a single- institution experience. Journal of Clinical Oncology. 2007 Jun 20;25(18_suppl):20531-.
• Saini KV, Kumari P, Saini ML, Latha P, Jain A, Kv S, Batra U, Attili A, Lakshmidevi V, Lakshmaiah K, Bapsy P. Chronic myeloid leukemia with variant translocations: A cytogenetic profile. Journal of Clinical Oncology. 2007 Jun 20;25(18_suppl):17517-.
• Attili SV, Anupama G, Dadhich HK, Saini KS, Bapsy PP, Batra U. Skin reactions with imatinib in CMLpatients: An Indian experience. Journal of Clinical Oncology. 2006 Jun 20;24(18_suppl):16522-